Physician profile
Fernando Ortiz
NPI 1013350636
$12,776.22
in general payments reported to CMS, 2019-2025
35 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4.40 · 2020: $10.94 · 2021: $1,145 · 2022: $852 · 2023: $5,390 · 2024: $2,995 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,125 · Travel and Lodging: $3,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,125.41 |
| Travel and Lodging | $3,637.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,302.98 | 2021-2023 | Optis |
| Angiodynamics, INC. | $2,264.03 | 2023-2025 | Angiovac, Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $2,239.53 | 2021-2025 | Indigo System, Penumbra System |
| Abiomed | $741.21 | 2021-2025 | Impella |
| Amgen INC. | $544.56 | 2022-2025 | Repatha, Repatha |
| Bard Peripheral Vascular, INC. | $436.27 | 2021-2025 | Rotarexs 6 F X 135 Cm, Venovo, True Flow |
| Boston Scientific Corporation | $430.18 | 2021-2023 | Avvigo Guidance System |
| Cvrx, INC. | $311.64 | 2024-2025 | Barostim Neo System |
| Recor Medical INC | $307.15 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Medtronic, INC. | $299.74 | 2022-2024 | Onyx Frontier |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.79 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $264.04 | 2022-2025 | Camzyos, Eliquis |
| Verge Medical, INC. | $247.45 | 2025 | Ostial Flash System |
| Lexicon Pharmaceuticals, INC. | $193.10 | 2023-2024 | Inpefa |
| Cordis US Corp. | $160.69 | 2024 | Selution Slrpta |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspiremd LTD | $144.17 | 2025 | Cguard Prime Carotid Stent System |
| Pfizer INC. | $137.19 | 2022-2025 | |
| Limflow INC. | $134.62 | 2023 | Limflow System |
| Stryker Corporation | $133.90 | 2025 | Limflow System |
| Bayer Healthcare Pharmaceuticals INC. | $130.69 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $123.07 | 2022-2023 | |
| Philips North America LLC | $120.27 | 2022-2024 | (Ck6) Holter |
| W. L. Gore & Associates, INC. | $117.93 | 2025 | Gore Cardioform Septal Occluder |
| Abbvie INC. | $115.00 | 2021 | |
| Biogen, INC. | $114.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $111.76 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $88.19 | 2022-2025 | Verquvo |
| Cardiovascular Systems INC. | $84.49 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $55.74 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $37.28 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $37.13 | 2023 | Arcalyst |
| Cms Imaging, INC. | $32.77 | 2025 | |
| Lemaitre Vascular, INC. | $13.80 | 2023 | Artegraft Vascular Graft |
| Kerecis Limited | $13.57 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.